Danial E Baker

Author PubWeight™ 14.15^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus.	Clin Ther	2006	1.02
2	Phosphodiesterase 5 inhibitors for erectile dysfunction.	Ann Pharmacother	2005	0.95
3	Insulin glargine: a new basal insulin.	Ann Pharmacother	2002	0.90
4	Inhaled dry powder insulin for the treatment of diabetes mellitus.	Clin Ther	2007	0.77
5	New concepts in diabetes: how multihormonal regulation can improve glycemic control.	J Manag Care Pharm	2004	0.76
6	Irinotecan Liposome Injection.	Hosp Pharm	2017	0.75
7	Bezlotoxumab.	Hosp Pharm	2017	0.75
8	Sugammadex.	Hosp Pharm	2016	0.75
9	Surrogate Markers and Drug Approvals.	Hosp Pharm	2016	0.75
10	High Drug Prices: So Who Is to Blame?	Hosp Pharm	2017	0.75
11	Patiromer.	Hosp Pharm	2016	0.75
12	Elbasvir/Grazoprevir.	Hosp Pharm	2016	0.75
13	Lixisenatide.	Hosp Pharm	2017	0.75
14	Daclizumab.	Hosp Pharm	2016	0.75
15	Defibrotide.	Hosp Pharm	2016	0.75
16	Uridine Triacetate.	Hosp Pharm	2016	0.75
17	Eteplirsen.	Hosp Pharm	2017	0.75
18	Mepolizumab.	Hosp Pharm	2016	0.75
19	Zika Virus and the Media.	Hosp Pharm	2016	0.75